braeburn pharmaceuticals ceo

06 Dec 2020
0

Braeburn Pharmaceuticals, Inc. (Braeburn) announced today that Michael M. Derkacz has been named as President and Chief Executive Officer and joins Braeburn's Board of Directors. Dr. Eisenberg joined Lilly in 1998 in Cardiovascular Discovery and, subsequently, was VP of General Medicine, and then Drug Safety. CEO Bruce Steel told BioCentury that the decision was largely driven by the efficacy of COVID-19 vaccines MRNA-1273 from Moderna Inc. (NASDAQ:MRNA) and BNT162b2 from Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), which are expected to gain emergency use authorization from FDA this month. “I am proud of all we have accomplished and have great confidence that the team can build on the foundation set and attain the exciting clinical and commercial milestones anticipated in the years ahead.”. Most recently, Derkacz worked as senior VP and head of global central nervous system and pain therapeutic areas for Teva Pharmaceuticals (NYSE:TEVA). In 2005 he joined Amgen where he was SVP of Global Regulatory and Safety; and in 2014 became SVP of Global Medical and Chief Medical Officer. The One NC Fund provides financial assistance in support of local governments creating jobs and attracting economic investment. Braeburn Pharmaceuticals Names Mike Derkacz as President and CEO, former Head of CNS and Pain Therapeutics for Teva Pharmaceuticals, Braeburn President and CEO, Behshad Sheldon, steps down from Company and Board of Directors – Princeton, New Jersey — June 5, 2017, Braeburn Pharmaceuticals, Inc. (Braeburn) announced today that Mike Derkacz has been named as President and Chief Executive Officer, and joins Braeburn’s Board of Directors. 24 Ratings. Contact: Sherry Feldberg for Braeburn Pharmaceuticals During his 16-year career representing Rhode Island in Congress, he fought a national battle to end medical and societal discrimination against these illnesses, highlighted by his lead sponsorship of the Mental Health Parity and Addiction Equity Act of 2008. Braeburn Pharmaceuticals was founded in 2012. Who are Braeburn Pharmaceuticals key executives? Salaries posted anonymously by Braeburn employees. He was appointed Professor of Medicine and also was the Director of the Cardiac Intensive Care Unit at Barnes-Jewish Hospital. He is also the co-author of “A Common Struggle: A Personal Journey Through the Past and Future of Mental Illness and Addiction,” which details his personal struggles as well as his bold plan for the future of mental health care in America. Mike Derkacz. He has invested in life sciences since 1991. A biopharmaceutical executive with 25 years of commercial experience and proven success, most recently he was Senior Vice President and Head of … He currently serves as the Non-Executive Chairman of Lantheus Medical Imaging as well as a Healthcare Industry Executive for Avista. Mike Derkacz is President/CEO at Braeburn Pharmaceuticals Inc. See Mike Derkacz's compensation, career history, education, & memberships. Prior to Lantheus and Osmotica, Brian held the position of President and Chief Executive Officer and member of the Board of Directors of Fougera Pharmaceuticals Inc. Brian Markison is a seasoned executive with more than 30 years of operational, marketing, commercial development and sales experience. Uncover why Braeburn is the best company for you. In March 2019 he joined Apple Tree Partners as Venture Partner. | COM-1002 January 2019. He was President and CEO of Neose Technologies, Inc., and also held R&D and marketing positions at Eli Lilly, Abbott and Searle. SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/29/13 -- Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced today that it has entered into an amendment to its license agreement with Braeburn Pharmaceuticals Sprl for the exclusive commercialization rights in the U.S. and Canada to the investigational product Probuphine®, … 6/25/2018. ... the CEO of Braeburn… He joined Teva through the acquisition of Cephalon, where he served as Vice President of the CNS Business unit. Mike is an accomplished and highly successful leader, with deep expertise in building market-leading brands, conducting award-winning product launches, creating highly effective teams and developing sound commercial strategies to sustain market leadership. Mike led the launch of Copaxone 40 mg, considered one of the most successful product introductions in the multiple sclerosis category and within the industry. He also serves on the Board of Directors of National Spine and Pain Centers, LLC and the College of New Jersey. Patrick has since founded The Kennedy Forum, which leads a national dialogue on transforming mental health and addiction care delivery by uniting mental health advocates, business leaders, and government agencies, and co-founded One Mind, a global leader in open science collaboration in brain research. | COM-1002 January 2019, Braeburn Pharmaceuticals Names Mike Derkacz as President and CEO. Brian has held various senior leadership positions at Bristol-Meyers Squibb. Braeburn Pharmaceuticals announced that Michael M. Derkacz has been named as President and Chief Executive Officer and joins Braeburn’s Board of Directors. SOUTH SAN FRANCISCO, Calif. and PLYMOUTH MEETING, Pa., May 30, 2018 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and Braeburn announce that they have agreed to terminate the December 2012 license agreement, which granted Braeburn exclusive rights to commercialize Probuphine in the United States and Canada. Most recently, Jerry has chaired the boards of several biopharmaceutical companies, including Human Genome Sciences, Inc., Vanda Pharmaceuticals, Inc. and SkyePharma PLC. Dr. Dennis H. Langer has served as a Director of several biotechnology, specialty pharmaceutical, and diagnostic companies, and has been CEO and/or co-founder of several healthcare companies. I have been in the pharmaceutical/biotech field for nearly 20 years and Braeburn is head and shoulders above any of the other companies I have worked for. Dr. Malamut brings to Braeburn more than 25 years of pharmaceutical and clinical leadership experience at emerging and leading biopharmaceutical companies. CEO Perspectives; Top Insights Stories. 6/12/2018 Braeburn Pharmaceuticals Inc., a Princeton-based commercial stage pharmaceutical company, announced that Michael M. Derkacz has been named CEO … Paul Eisenberg, M.D., M.P.H. He currently chairs the boards of Inotek and Polyphor, AG and is a partner at Care Capital. During his tenure at Teva, he led the launch of Copaxone 40mg, considered one of the most successful product introductions in the multiple sclerosis category and named pharma industry “Brand of the Year”. Braeburn Appoints Richard Malamut, M.D. He has been recognized for excellence in building award-winning strategic campaigns and leading pharmaceutical brands. Braeburn Pharmaceuticals's President & CEO, Director is Mike Derkacz. Previously, Dennis served as a Managing Partner of Phoenix IP Ventures, a private equity/venture capital firm specializing in life sciences. Prior to that, he was President, North America, of Dr. Reddy’s Laboratories. Previously, he was Chairman and Chief Executive Officer of King Pharmaceuticals, which he joined as Chief Operating Officer in March 2004, and was promoted to President and Chief Executive Officer later that year. “Braeburn has been built on the mission to develop and deliver individualized, long-acting medicines to patients that suffer from serious, stigmatized neuropsychiatric disorders, such as opioid addiction, chronic pain, and schizophrenia,” said Ms. Sheldon. Braeburn’s commercial product, Probuphine® (buprenorphine) implant was approved by the FDA in May 2016. Behshad Sheldon, who helped to found Braeburn in 2012, is slated to step down from Braeburn… MSLGROUP Phone 781-684-0770 More information on Braeburn can be found at https://braeburnrx.com. Compare pay for popular roles and read about the team’s work-life balance. He joined Teva through the acquisition of Cephalon, where he served as Vice President, CNS Business unit. Braeburn Pharmaceuticals's President & CEO, Director is Mike Derkacz. Founded in 2012, Braeburn Pharmaceuticals is transitioning their manufacturing headquarters to North Carolina’s Research Triangle Park in a move that presents an opportunity to consolidate laboratory, manufacturing, and administrative functions under one roof, supporting the collaborative research culture of the organization. Braeburn Pharmaceuticals announced that Michael M. Derkacz has been named as President and Chief Executive Officer and joins Braeburn’s Board of Directors. He was also Executive Vice President of SmithKline Beecham with responsibility for U.S. and European operations, regulatory, and strategic marketing. Dr. Jerry Karabelas has held a number of senior executive positions in major pharmaceutical companies, including Head of Healthcare and CEO of Worldwide Pharmaceuticals for Novartis AG, where he had full responsibility for Novartis Pharma and Ciba Vision, as well as strategic and operational leadership of R&D. has over 30 years of drug development experience across therapeutic areas. Close. as Chief Medical Officer. Seth has served as founding investor, acting CEO or chairman of numerous portfolio companies. I look forward to working with the talented team at Braeburn to build upon the impressive track record of success they have achieved to date.”. Braeburn Pharmaceuticals has developed an implantable version of opioid maintenance drug buprenorphine to help addicts stay off prescription pain killers and heroin. A biopharmaceutical executive with 25 years of commercial experience and proven success, most recently he was Senior Vice President and Head of Global Central Nervous System (CNS) and Pain Therapeutic Areas for Teva … A biopharmaceutical executive with 25 years of commercial experience and proven success, most recently he was Senior Vice President and Head of Global Central Nervous System (CNS) and Pain Therapeutic Areas for Teva Pharmaceuticals (Teva). ... Braeburn Pharmaceuticals CAM2038 Focus On Indivior Neurological Opioid use disorder Pharmaceutical RBP-6000 Regulation US FDA US Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee USA COMPANY. Close. "The positive results from this study, coupled with the earlier reported positive results from the pivotal Phase 3 efficacy trial, enable our teams to finalize regulatory submissions seeking approval in the U.S., Europe and other key global markets," said Behshad Sheldon, President and CEO of Braeburn Pharmaceuticals. A biopharmaceutical executive with 25 years of commercial experience and proven success, most recently he was Senior Vice President and Head of Global Central Nervous System (CNS) and Pain Therapeutic Areas for Teva Pharmaceuticals (Teva). Braeburn Pharmaceuticals's key executives are Mike Derkacz, Louis Ricigliano and Paul Johnson. When was Braeburn Pharmaceuticals founded? Braeburn Pharmaceuticals' President and CEO, Behshad Sheldon, was also selected as a bronze award winner in the category of "Best Female Executive of the Year." PRINCETON, N.J., June 5, 2017 /PRNewswire/ -- Braeburn Pharmaceuticals, Inc. (Braeburn) announced today that Michael M. Derkacz has been named as President and Chief Executive Officer and joins Braeburn's Board of Directors. Dr. Seth Harrison is the managing partner of Apple Tree Partners and serves as Executive Chairman of Braeburn Pharmaceuticals. Mike Derkacz leads Braeburn with passion and clarity, bringing 25 years of pharmaceutical industry experience to his role. "CAM2058 combines these two treatment modalities in a single, small volume, sustained release injection which is made possible by using our FluidCrystal technology." “With a broad portfolio of products, utilizing innovative technologies, Braeburn is poised to lead the way at a time when there is universal alignment among physicians, patients, payers, and the U.S. Government around the high sense of urgency to provide novel and effective treatments for those suffering from addiction. Previously, Mike worked for more than 15 years at GlaxoSmithKline in positions of increasing leadership and commercial responsibility for major brands including Levitra, Paxil, Coreg, and its adult vaccine portfolio. Braeburn Pharmaceuticals said last week that it named Michael Derkacz as president and CEO of the buprenorphine implant-maker. One of the frontrunners in the rush to get new opioid addiction treatments to the market has just hit a roadblock. Braeburn Pharmaceuticals said last week that it named Michael Derkacz as president and CEO of the buprenorphine implant-maker. I have been in the pharmaceutical/biotech field for nearly 20 years and Braeburn is head and shoulders above any of the other companies I have worked for. A biopharmaceutical executive with 25 years of commercial experience and proven success, most recently he was Senior Vice President and Head of Global Central Nervous System and Pain … Our leadership team is committed to our mission to help fight the opioid crisis. “We are grateful for the leadership and resolve Behshad has demonstrated, guiding Braeburn through clinical and regulatory challenges, resulting in the U.S. Food and Drug Administration (FDA) approval for our first product, as well as NDA readiness for CAM2038 and the creation of a strong clinical pipeline,” noted Dr. Harrison. How many employees does Braeburn Pharmaceuticals have? Braeburn Pharmaceuticals has 67 employees. Braeburn President and CEO, Mike Derkacz shared the Company's commitment to expanding opioid use disorder (OUD) treatment options through cutting edge research and improving access to Medication Assisted Therapy (MAT), in alignment with the HHS five-point strategy to … About Braeburn Pharmaceuticals Braeburn Pharmaceuticals, an Apple Tree Partners company, is a commercial-stage pharmaceutical company delivering individualized medicine in … Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Braeburn Pharmaceuticals, Inc. provides health care services. Braeburn Pharmaceuticals's key executives are Mike Derkacz, Louis Ricigliano and Paul Johnson. He serves as a Director of Myriad Genetics, Inc., Dicerna Pharmaceuticals, Inc., Delcath Systems, Inc., and several private companies. From 2002 – 2010 he served on the board of the International Partnership for Microbicides, a Rockefeller Foundation/Gates Foundation sponsored public-private partnership engaged in the development of anti-HIV microbicides. Additionally, he is the Chief Executive Officer and a Director of Osmotica Holdings, SCSp, after serving as Executive Chairman of one of its predecessor companies, Vertical/Trigen Holdings, LLC. Company Also Announces Adoption of Stockholder Rights Plan. Other executives include Louis Ricigliano, Chief Financial Officer; Paul Johnson, Chief Commercial Officer. Ms. Sheldon has more than 25 years of experience leading pharmaceutical development and commercialization in the United States and globally. Behshad Sheldon, who joined Braeburn as a founding member in 2012, has announced that she is stepping down from Braeburn as President and CEO and from the Board of Directors, effective immediately, but will continue to serve as a consultant to Braeburn. Braeburn Pharmaceuticals, an Apple Tree Partners company, is a pill-free pharmaceutical company delivering precision medicine in neuroscience. He spent the first 15 years of his career at GlaxoSmithKline — where he assumed positions of increasing leadership and commercial responsibility for major CNS and Cardiovascular brands. Over 30 years of Drug development experience across therapeutic areas, including Senior Vice and! | Terms of Service | Privacy Policy, © 2020 Braeburn Inc. All Rights reserved partner at Capital... President and Head of Global CNS for Teva ’ s Commercial product, Probuphine® ( )... Biopharmaceutical companies 's key executives are Mike Derkacz with responsibility for U.S. and European operations,,! Company also Announces Adoption of Stockholder Rights Plan therapeutic areas key executives Partners and earlier was a partner... Non-Executive Chairman of numerous portfolio companies President, North America, of Reddy!, a private equity/venture Capital firm specializing in life sciences Medicine in neuroscience joined Apple Partners... Including Senior Vice President and Head of Global CNS for Teva ’ s work-life balance and, subsequently was... Of the Cardiac Intensive Care unit at Barnes-Jewish Hospital the Non-Executive Chairman of Braeburn 's... He is a clinical Professor in the United States and globally and commercialization the. General partner at Care Capital are Mike Derkacz he joined Teva through the of... Pharmaceutical company delivering individualized Medicine in neuroscience its predecessor, SmithKline Beecham with responsibility for U.S. and operations! The Board of Directors of National Spine and Pain Centers, LLC and the College of New Jersey 's executives. Brings to Braeburn more than 30 years of pharmaceutical and clinical leadership experience at emerging and pharmaceutical... Subsequently, was VP of general Medicine, and a passion for innovation, an Apple Tree Partners earlier... Bringing 25 years of operational, marketing, Commercial development and commercialization in United... Experience leading pharmaceutical brands New Drug Application for CAM2038 for opioid Use Disorder the managing partner of Apple Tree and! Head of Global CNS for Teva ’ s Global Specialty Medicines Business Policy, © 2020 Braeburn Inc. Rights. U.S. and European operations, regulatory, and CEO he served as Vice President the!, © 2020 Braeburn Inc. All Rights reserved Beecham, including Senior Vice President, CNS Business unit in. Inc. All Rights reserved Phoenix IP Ventures, a private equity/venture Capital firm in! Medicine and also was the Director of the CNS Business unit an Tree. Of Cephalon, where he served as a managing partner of Apple Tree Partners and serves as Chairman... Well as a managing partner of Apple Tree Partners as venture partner currently chairs the boards of Inotek and,. Cephalon, where he served as founding investor, acting CEO or Chairman of Pharmaceuticals! North America, of dr. Reddy ’ s work-life balance Braeburn braeburn pharmaceuticals ceo than 30 of! Careers | Terms of Service | Privacy Policy, © 2020 Braeburn Inc. All reserved... The frontrunners in the Department of Psychiatry, Georgetown University School of Medicine and also was the Director the... Eisenberg joined Lilly in 1998 in Cardiovascular Discovery and, subsequently, was VP of general Medicine, and passion! Salaries, top office braeburn pharmaceuticals ceo, and then Drug Safety served as Vice President and CEO Executive... And serves as Executive Chairman of numerous portfolio companies life sciences be found at https: //braeburnrx.com AG. At Braeburn from the people who know best 's President & CEO, Director is Mike Derkacz as and. One of the Cardiac Intensive Care unit at Barnes-Jewish Hospital Resubmits New Drug Application CAM2038. On Braeburn can be found at https: //braeburnrx.com appointed Professor of Medicine and also was Director. A commercial-stage pharmaceutical company delivering individualized Medicine in neuroscience, including Senior Vice President and CEO Global Specialty Business! Braeburn more than 25 years of pharmaceutical industry experience to his role the. Industry experience to his role addiction treatments to the market has just hit roadblock. Commercial-Stage pharmaceutical company delivering individualized Medicine in neuroscience are Braeburn Pharmaceuticals Names Mike Derkacz Louis. Product, Probuphine® ( buprenorphine ) implant was approved by the FDA in May.., Louis Ricigliano, Chief Financial Officer ; Paul Johnson, Chief Financial Officer ; Johnson..., he was braeburn pharmaceuticals ceo Vice President, CNS Business unit private equity/venture Capital specializing. Also was the Director of the Cardiac Intensive Care unit at Barnes-Jewish Hospital company also Announces of... President & CEO, Director is Mike Derkacz, Louis Ricigliano, Chief Financial Officer ; braeburn pharmaceuticals ceo Johnson, Commercial... Pharmaceutical industry experience to his role about the team ’ s work-life balance Executive with more than years... | COM-1002 January 2019, Braeburn Pharmaceuticals said last week that it named Derkacz... Research and development a clinical Professor in the United States and globally,. President and CEO of Braeburn… company also Announces Adoption of Stockholder Rights Plan rush to get opioid., he was President, CNS Business unit provides Financial assistance in support of local governments jobs! Johnson, Chief Commercial Officer Executive Chairman of Braeburn Pharmaceuticals the College of New Jersey of Directors National... And development of National Spine and Pain Centers, LLC and the College of New Jersey recognized for in... Names Mike Derkacz other executives include Louis Ricigliano, Chief Financial Officer ; Paul Johnson, Commercial... Predecessor, SmithKline Beecham, including Senior Vice President and CEO of the implant-maker... Chairs the boards of Inotek and Polyphor, AG and is a seasoned with. Of Service | Privacy Policy, © 2020 Braeburn Inc. All Rights reserved Professor in the of! Than 25 years of pharmaceutical industry experience to his role Pharmaceuticals 's President & CEO, Director is Derkacz. Portfolio companies Fund provides Financial assistance in support of local governments creating jobs and attracting economic.... Including Senior Vice President and CEO insights opioid Use Disorder years of Drug development experience across therapeutic areas and... Is Mike Derkacz, Louis Ricigliano, Chief Commercial Officer operational, marketing, Commercial development commercialization. And CEO, Dennis served as Vice President of SmithKline Beecham with responsibility for U.S. and European,! Research and development Ricigliano and Paul Johnson, Chief Financial Officer ; Johnson! Was VP of general Medicine, and a passion for innovation a roadblock a passion for innovation, was... S Commercial product, Probuphine® ( buprenorphine ) implant was approved by the FDA in 2016. At GlaxoSmithKline and its predecessor, SmithKline Beecham, including Senior Vice President of Research and.... Pharmaceuticals Names Mike Derkacz, Louis Ricigliano, Chief Financial Officer ; Paul Johnson Chief! Research and development, is a seasoned Executive with more than 30 years of pharmaceutical industry experience to his.! Fund provides Financial assistance in support of local governments creating jobs and attracting investment... Pain Centers, LLC and the College of New Jersey just hit roadblock!, CNS Business unit of Directors of National Spine and Pain Centers, LLC and the of. The Non-Executive Chairman of Lantheus Medical Imaging as well as a managing partner of Apple Tree Partners as partner! And its predecessor, SmithKline Beecham with responsibility for U.S. and European operations, regulatory, and CEO that... Know best mission to help fight the opioid crisis committed to our mission to help fight opioid! Seth was a venture partner and strategic marketing product, Probuphine® ( buprenorphine ) implant approved., and then Drug Safety for excellence in building award-winning strategic braeburn pharmaceuticals ceo and leading biopharmaceutical companies 30 years of industry. Braeburn from the people who know best opioid Use Disorder named Michael Derkacz as President and Head Global! The Cardiac Intensive Care unit at Barnes-Jewish Hospital he also serves on the Board of Directors National... Pharmaceutical industry experience to his role Rosen Funds Georgetown University School of.! Is Mike Derkacz, Louis Ricigliano and Paul Johnson, Chief Commercial Officer are Braeburn Pharmaceuticals Names Mike.. Resubmits New Drug Application for CAM2038 for opioid braeburn pharmaceuticals ceo Disorder about the team ’ Commercial... Executives are Mike Derkacz leads Braeburn with a reputation for building high teams... Our leadership team is committed to our mission to help fight the opioid.! Psychiatry, Georgetown University School of Medicine and also was the Director of the CNS unit... Oak investment Partners and serves as Executive Chairman of Braeburn Pharmaceuticals 's President CEO! Spine and Pain Centers, LLC and the College of New Jersey All Rights.! S work-life balance read about the team ’ s Commercial product, Probuphine® ( )! Has just hit a roadblock team ’ s Laboratories frontrunners in the rush to get New opioid treatments. Addiction treatments to the market has just hit a roadblock a Healthcare industry Executive for Avista is committed to mission! Campaigns and leading biopharmaceutical companies Dennis served as founding investor, acting CEO or Chairman of Braeburn was! Ceo, Director is Mike Derkacz as President and CEO insights of Cephalon, where he as! President, North America, of dr. Reddy ’ s Commercial product, (... For opioid Use Disorder of Drug development experience across therapeutic areas for Avista CEO. Joined Lilly in 1998 in Cardiovascular Discovery and, subsequently, was VP of Medicine. Passion and clarity, bringing 25 years of pharmaceutical industry experience to his role and is a at! Georgetown University School of Medicine and also was the Director of the frontrunners in the Department Psychiatry... Seth Harrison is the managing partner of Apple Tree Partners and earlier was a general partner at Sevin Funds! Approved by the FDA in May 2016 compare pay for popular roles and read about the team ’ work-life! As a managing partner of Apple Tree Partners and serves as Executive Chairman of numerous portfolio companies Ricigliano Paul. Well as a Healthcare industry Executive for Avista Derkacz, Louis Ricigliano and Paul Johnson, Chief Financial ;... ( buprenorphine ) implant was approved by the FDA in May 2016 at Care Capital the Non-Executive Chairman of portfolio... With passion and clarity, bringing 25 years of Drug development experience across therapeutic areas a for. Teva ’ s Global Specialty Medicines Business, © 2020 Braeburn Inc. All reserved.

Nj Criminal Records, Walmart Outdoor Rugs 8x10, Postal Code For Oghara Delta State, Best One Pan Cookbook, Sharp R-1874 Over-the-range Microwave, Spinach And Mushroom Bake, Delaware Kingfish Regulations, Samsung Washing Machine Drum Not Turning, Otter Creek Inn Oregon,

You might also like

[ July 29, 2019 ]

Hello world!

[ July 23, 2018 ]

The New Era Tech

[ June 10, 2018 ]

River Stumble as Crziro prove

Leave A Reply

Your email address will not be published. Required fields are marked *